SWAG Cancer Alliance Programme Manager
|
|
- Carmel Palmer
- 5 years ago
- Views:
Transcription
1 Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance Minutes of the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Board Meeting held on Friday 9 th June :00-12:00 Conference Room, Trust Headquarters, Bristol Royal Infirmary, BS2 8HW Present: Dr Amelia Randle James Rimmer (Chair) Jonathan Miller Patricia McLarnon Asha Sahni Helen Dunderdale Anna Field Beverley Haworth Dr Glenda Beard Samuel Wadham Marissa Morris Maggie Crowe Nigel Andrews Tariq White Ardiana Gjini Sarah Dove Ulrike Harrower Kathryn Hall Dr Sadaf Haque Rachel Rowe Hannah Marder Ruth Hendy Steve Maddern Representing: SWAG Cancer Alliance Programme Management Team SWAG Cancer Alliance Clinical Lead SWAG Cancer Alliance Executive Lead SW Cancer Programme Lead SWAG Cancer Alliance Programme Manager SWAG Cancer Alliance Services Administrative Coordinator SWAG Cancer Alliance Services SSG Support Manager Bath, Swindon and Wiltshire STP Cancer Group Associate Director for Commissioning Swindon CCG BNSSG STP Cancer Group Senior Project Manager Bristol CCG GP Clinical Lead for Cancer Bristol CCG Cancer Manager North Bristol NHS Foundation Trust Cancer Research UK Primary Care Engagement Facilitator Macmillan Cancer Support Macmillan Partnership Manager NHS England South of England Programme of Care Lead for Cancer, Specialised Commissioning Assistant Director of Transformation and Outcomes Public Health England Screening & Immunisation Lead Bath, Gloucestershire, Swindon, Wiltshire SW Screening & Immunisation Bristol CCG Consultant in Healthcare Public Health One Gloucestershire STP Cancer Group Associate Director, Service Redesign Gloucestershire Macmillan General Practitioner Gloucestershire CCG Somerset STP Cancer Group Clinical Networks Programme Manager Somerset CCG SWAG Cancer Operational Group Cancer Manager University Hospitals Bristol FT Lead Cancer Nurse University Hospitals Bristol FT Guest Acting Public Health Consultant Wiltshire Local Authority Page 1 of 9
2 Apologies: Caroline Powell Dr Dorothy Goddard Ed Murphy Georgia Diebel Jill Ireland John Graham Julie Yates Dr Nicola Harker Rosie Edgerley Director of Intelligence SWAHSN Senior Consultant and Associate Medical Director RUH Strategic Partnership Manager SW England Macmillan Facilitator Manager SW Health Professional Engagement, Cancer Research UK Health Professional Engagement Manager Cancer Research UK Consultant in Clinical Oncology, TSTFT Lead Consultant SW Screening & Immunisation Macmillan GP BNSSG Rotational STP Representative General Manager Surgical Directorate WGH BNSSG Rotational STP Representative 1. Welcome and Introductions J Rimmer welcomed all group members; it was noted that that all 4 STPs in the region had representation at the meeting. 1.1 Review of previous meeting s notes (10 th March 2017) The last paragraph of Page 4 does not fully reflect issues that were articulated at the last meeting. Appropriate wording will be provided. 018/17: Action B Haworth With the inclusion of the amendment above the minutes were agreed as a true record of the meeting on 10 th March Review of previous meeting s actions 003/17. Breast cancer services to work together in a sustainable model has been reinstated in the work programme. 004/17. STP chairs were ed at the end of April introducing the Cancer Alliance team and with a request to identify the executive lead SRO for cancer with a view to having them as a member of the board; however no responses were received. It was agreed that STP chairs might choose to delegate responsibility and that what was crucial was that STP representatives had a clear reporting structure to ensure that STP chairs were kept up to date with Cancer Alliance issues. 010/17. The skin pathway was discussed at the skin SSG meeting on 16 th May Whilst there are systems in place to ensure results are actioned there was recognition that the mechanism for communication between primary care and pathology was a broader issue. BNSSG is happy to progress this issue and it will be brought back to the next meeting for resolution. 019/17: Action B Haworth Page 2 of 9
3 011/17. Each STP cancer group is due to respond to SWAG Cancer Alliance about their approach to the use of Commissioning through Evaluation packs by the end of June Making Every Contact Count (MECC) Presented by Steve Maddern (SM) Acting Consultant Public Health, Wiltshire Council and BSW MECC steering group chair Making Every Contact Count enables organisations and individuals to develop and be able to use a different approach to working with people to address health and wellbeing. Telling people what to do is not the most effective way to help them to change. Making Every Contact Count is about altering how professionals interact with people through learning how to recognise opportunities to talk to people about their wellbeing. It was noted that MECC is within the NHS England 2016/17 NHS Standard Contract Service Conditions and each STP has this approach within their prevention workstream. The board acknowledged MECC s role within the cancer agenda particularly with early diagnosis and the Living with and beyond cancer (LWBC) agenda by supporting: Promoting screening uptake Promoting cancer campaigns Promoting healthy lifestyles getting more active, quitting smoking, drinking less alcohol MECC training is delivered through an e-learning package and 2 half day sessions. Train the Trainer courses give people the tools to help cascade the MECC message throughout their organisation, creating MECC champions as part of this process. A MECC Coordinator is being recruited and a grants scheme will be implemented to help smaller organisations engage with MECC. It is hoped that support at STP level can be used as a lever to encourage organisations to buy in to the MECC message. MECC will feed in to prevention/early intervention STP groups; funding has come from STPs so MECC is accountable to them. Meeting attendees were encouraged to speak to their STP MECC lead and explore ways of accessing the training for the cancer workforce. 3.0 Transformation Bids 3.1 Bids status 020/17: STP cancer groups to explore with local MECC leads Deadlines for resubmission of transformation bids are now 7 th July for Early Diagnosis and 1 st September for LWBC. NHS England has prioritised the delivery of the 62 day cancer standard and NHS England South has been allocated 2,900,000 from the National Cancer Transformation Fund to support this work. Access to Cancer Transformation funding locally will now be linked to delivery of this standard. It is unknown at this point in time if there is less funding now available and if so whether the bids need to be amended to reflect the reduction in available funding. It was agreed in the absence of feedback resubmission of Page 3 of 9
4 bids will include original costs and timings as in year equivalents may be approved. It was noted that the original LWBC bid had not addressed one of the metrics for delivering HNAs (successful bids all had a target for this metric) this may have been a factor in the bids not getting through first time. It was agreed that the LWBC group should convene a meeting to agree a way forwards 3.2 Early Diagnosis Lung pathway progress report 021/17: Action P McLarnon The Somerset reporting tool for chest x-rays was presented at the Lung SSG by the Alliance clinical lead. SWAG radiologists are meeting on 21 st July to agree a universal reporting tool for SWAG and a proposed implementation date of November Prevention and Early Diagnosis Working Group Proposal The board approved a Prevention and Early Diagnosis group; A Randle will take the lead in establishing the group. 022/17: Action A Randle 4.0 Quality Improvement 2WW Referrals Proposal When discussing implementation of the CXR reporting tool at the SSG a question that has regularly arisen is how do we plan to work with GPs to improve quality of referral information? Criticism of referral quality is a source of frustration to many GPs who pride themselves on high standards, although many accept there is variation in practice. There is also a variation in understanding of what information is useful to secondary care teams. A Randle proposed introducing a two week wait referrer s code which would work in a similar way to a smear taker s code. Initially GPs would be issued a code and invited to voluntarily enter the code when making 2ww referrals. In return for this they would be given a report of performance annually to use in appraisals. The emphasis would be on quality of referral information rather than clinical judgement. Participation would initially be voluntary with the potential for making it compulsory in due course, i.e. referrals only accepted if with a 2ww referrer s code. In principle this could lead to improved referrals, better demand management and more appropriate patient investigations with the potential for improvements in cost, clinical effectiveness and patient experience. It would maintain best practice as the primary care workforce diversifies and would include Allied Health Professionals who make 2ww referrals, thus ensuring receive a minimum standard of training. Board consensus was that this could be perceived as performance management rather than a quality improvement initiative and therefore needed to be explored further with GP colleagues and revisited at the next meeting. 5.0 Data and Analysis Work Programme 023/17: Action A Randle Page 4 of 9
5 The Cancer Alliance has a number of inter-related information and analysis needs including: Monitoring progress towards Cancer Alliance objectives Monitoring local progress with the ambitions of the National Cancer Strategy. Information to support capacity planning Information to support delivery of cancer waiting times Understanding of the cost effectiveness of various cancer services to help identify opportunities for increasing value for money in cancer services. The board were asked to approve commissioning of a south wide cancer dashboard provided by the South Central and West Commissioning Support Unit. The commissioning of the dashboard was approved in principle; each STP cancer group will review the detail within the specification and respond with comments. 024/17: Action STP cancer groups/b Haworth Feedback on Dashboard progress will be provided at the next meeting. 6.0 Cancer Alliance Delivery Plan Actions from the March board included: Providing further clarity on the Alliance governance arrangements, in particular the working/reporting relationship with the STPs, STP cancer working groups, provider cancer boards, SSGs and QST. Rewriting the work plan with SMART deliverables. This work is in progress by the Programme Manager and will be published this summer. Factors that will influence the revised version Alliance delivery plan are: Outcomes of the National Meeting: Leading Change: Cancer Alliances National Launch held on 16 th June 2017 Further guidance from the national cancer team regarding governance of cancer alliances including the relationships between the alliances, DCO, regional and national teams. The national cancer team will also provide a defined, approved and communicated process for working with NHS Improvement, NHS England national and regional teams, Specialised Commissioning to unblock issues due at the end of June Regional gap analysis of Alliance and STP delivery plans against the 96 recommendations; for each quarter to 31 st March 2018 there will be agreement on the priorities to be addressed; the team/organisation that will lead on ensuring those gaps are addressed will be identified due at the end of June The priorities identified above will be communicated to Cancer Alliances and STPs with a request for them to be added to local delivery plans due at the end of August Outcome of the transformation funding bids. It was noted Alliance reporting against deliverables starts on 30 th September 2017 so as to provide reassurance to the regional programme board and national teams of progress. Page 5 of 9
6 In terms of local governance arrangements between each STP and STP cancer group the board were reassured by each cancer group that they had been endorsed by their respective STP as the STP cancer workstream and formal reporting arrangements were in place. It was proposed that a Lead Cancer Nurse be a core member of the Cancer Alliance board. The proposal was approved and will be discussed with SWAG Lead Cancer Nurses to agree representation. 025/17: Action R Hendy 6.1 Patient and Public Engagement (PPE) At the March board the STP cancer groups agreed to nominate a user representative to be a member of the board. Somerset and BSW confirmed they do not have user representation on their boards. BNSSG and Gloucestershire do have user representatives on their boards however they did not action this in time for the June board. The board were informed that on 28 th July the Cancer Alliance is hosting a patient and public involvement event. All stakeholders and user groups have been invited and the event should provide a good forum to explore with stakeholders how they can help support the implementation of the strategy. Once a pool of expert users has been identified the board can recruit user representatives from this group. 6.2 National Team The National Team update, circulated pre-meeting, was for information only. 7.0 Public Health England Update and Work Plan Presented by Dr Ardiana Gjini, Consultant in Public Health Medicine, Screening and Immunisation Lead: Bath, Gloucestershire, Swindon and Wiltshire Public Health England (PHE) focuses on prevention, inequalities, early diagnosis, reducing emergency presentations and lifestyle in relation to cancer. A cancer prevention work programme is to be agreed with Cancer Alliances for the 2017/18 year by November Nationally the PHE work plan is based on Taskforce Recommendations. The PHE work programme involves a number of priorities including: A new tobacco control plan within the next 12 months Obesity HPV vaccination the focus is on reducing HPV in girls aged HPV primary testing will be implemented across the country as the primary cervical screening method, replacing cytology testing workforce training is an issue and NBT are part of pilot. There is a pilot targeted HPV vaccination programme for men who have sex with men (MSM) aged up to and including 45 years who attend GUM and HIV clinics in Swindon, Bristol and Salisbury. It is looking at the impact of vaccination against penile, anal and oropharyngeal (head and neck) cancers, and genital warts. Evidence suggests that 80-85% of anal cancers, 36% of oropharyngeal and 50% of penile cancers are linked to HPV infection. Page 6 of 9
7 The Faecal Immonochemical Test (FIT) test the UK National Screening Committee (UKNSC) recommended the test should be rolled out nationally by It is expected to increase screening uptake by around 10% and result in around 200,000 more people a year being tested, potentially saving hundreds of lives. There is a national target of 75% uptake of FIT by 2020 a huge challenge. It was noted that the emphasis was on GPs to influence the uptake however they are unable to keep the kits within their practices. It was also noted that introduction of FIT could have potential impact on endoscopy capacity. UKNSC will publish evidence on lung and ovarian cancer screening later this year. Other activity which may impact on SWAG providers includes: A focus on interventions to increase screening uptake. Results of the PROTECT trial recommend a pre-biopsy multi-parametric MRI scan for the diagnostic workup of prostate cancer; radiology capacity would need to be increased to make this possible with parity across the region. The Public Health England respiratory campaign started with breathlessness and is moving to coughing from 6 th July, running for 14 weeks. BNSSG is working with health promotion and Cancer Research UK to address poor bowel screening uptake. It is hoped that the introduction of a GP endorsed letter will increase uptake (a 0.7% increase in uptake resulted from the national trial). Bowel scoping may not continue to be viable in Weston which could result in patients travelling to Bristol. Eastwood Park prison now has access to breast screening this will result in small numbers being screened at high cost. A new pathway for women with a high risk of breast cancer who need to be screened yearly needs is to be incorporated into the screening programme to ensure quality assurance. 8.0 Chemotherapy Group and Protocols 026/17: Action Slides to be shared with notes As a temporary measure following on from the previous ASWCS network the Network Chemotherapy Service is currently funded by the Strategic Clinical Network (SCN). Funding of the SCN is now time limited and it is not the appropriate vehicle for provision of this funding; future funding arrangements need to be agreed if the SWAG Alliance wishes to continue this service. Purpose of the Service - To maintain the protocols for chemotherapy regimens being delivered in the region. This ensures consistency, safety and good practice across the region - To develop new protocols when new chemotherapy regimens are introduced - To provide a forum for chemotherapy nurses, pharmacists and oncologists to meet, share good practice and ensure high standards are maintained Risks if the Service is Lost - Variation in practice across the region, leading to inequalities of care - Inefficient every Trust would need to develop their own protocols, requiring an equivalent amount of resource in every organisation Page 7 of 9
8 - Potential for risks to quality and safety as protocols will be developed in isolation without the benefits of collaboration - Loss of opportunity to share good practice and drive improvement - Negative impact on research if protocols for new trials cannot be developed in a timely way The board consensus was that the service should be funded as part of normal business for the SWAG providers and it needs to be worked in to the business planning rounds for pick up next year. SCN funding will cease at the end of March A letter from the board will be sent to each SWAG provider informing them of this decision. SWAG providers will be provided with a breakdown of proposed costs for the posts as of next financial year. The post holders contracts will be extended to March /17: Action H Marder, J Miller & J Rimmer It was agreed that the Cancer Alliance budget should be transparent and that ways to communicate this information would be reviewed. 028/17: Action J Miller 9.0 Achieving the 62 day standard The board reviewed a paper outlining an Alliance approach to delivering 62 day cancer performance at individual provider level within the Alliance. The paper proposed actions to enable a more sustainable approach to the 62 day cancer performance target. A review of local action plans and information from cancer services managers supports the view that the key issues for performance lie within the prostate, lung, colorectal and upper GI cancer pathways. Issues include all aspects of diagnostics (including histopathology and CT colonography) and delays are caused in the main by workforce, inpatient bed and theatre availability and late inter-trust referrals. The introduction of the breach allocation policy should help facilitate smoother inter-trust pathways. Improving performance across the system requires action across a number of areas including improving local operational issues as well as more strategic issues such as diagnostic capacity and improving key pathways. The proposed key actions are: 1. Projecting Cancer Activity 2. Ensuring Operational Excellence 3. Better approach to diagnostics 4. Changing pathways to be more effective Urology, lung and colorectal pathways account for the majority of 62 day cancer breaches across the Alliance. Therefore we are focussing work on improving these pathways using the support of site specific groups to gain clinical consensus. Prostate The redesign of the prostate pathway is being led by a Regional project, funded from the Diagnostics Capacity Fund. The Urology Site Specific Group has begun the work of understanding local pathways and how to implement the recent evidence form the PROMIS Page 8 of 9
9 study, which recommends multiparametric MRI before biopsy. North Bristol Trust is now the best performing specialist prostate cancer surgery provider in the South West and has published a review of the work undertaken to achieve this. Proposal: o o The SWAG Alliance will contribute to the regional project and implement revised pathways for prostate cancer All prostate surgical providers in the South West will meet to share best practice and agree improvements Lung Cancer Proposal: o The SWAG Alliance will introduce the national optimal lung cancer pathway with particular focus on streamlining the beginning of the pathway to reduce time between x-rays, CT and outpatient appointments Upper and Lower GI Cancers Proposal: o The SWAG Alliance will introduce straight to test pathways for all GI endoscopy procedures for all providers All the proposals were agreed in principle but more time was requested to help facilitate local discussion before feeding back to the Cancer Alliance; the deadline was extended to Friday 16 th June AOB 030/17: Action All providers to respond to proposals by Friday 16 th June It was agreed that a summary note of the meeting would be sent round to all partners Date and time of next meeting 029/17: Action J Miller Friday 8 th September 2017, South West House, Blackbrook Park Avenue, Taunton, TA1 2PX Page 9 of 9
Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationHealthwatch Bristol summary of the Bristol Health and Wellbeing Board meeting on 15 February 2017
Healthwatch Bristol summary of the Bristol Health and Wellbeing Board meeting on 15 February 2017 Healthwatch Bristol has a seat on the Health and Wellbeing Board to represent the views of people living
More informationNational Cancer Registration Service South West Cancer Alliance Manager NHS England South, South West
Present : Apologies: Meeting of the SWAG Area Cancer Operational Group (formerly ASW) Held on Wednesday 18 th April 2018, 10.00-12.00 Sanford Education Centre, Room 10, 32 Keynsham Road, Cheltenham, GL53
More informationCheshire and Merseyside Cancer Alliance. Helen Porter Director of Nursing and Quality 19 th April 2017
Cheshire and Merseyside Cancer Alliance Helen Porter Director of Nursing and Quality 19 th April 2017 Independent Cancer Taskforce Published five year strategy for cancer in July 2015 with aim to improve
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationTransforming Cancer Services Team
Transforming Cancer Services Team Healthy London Partnership Annual Report 2016/17 July 2017 Supported by and delivering for London s NHS, Public Health England and the Mayor of London Contents Who we
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Meeting of the SWAG Network Urology SSG Thursday 15 th March 2018, 13:30-17:00 Spire Specialist Care Centre, 300 Park Avenue, Aztec West Almondsbury, Bristol, BS32 4SY Chairs: Mr Jaspal Phull (JP) & Ms
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.15.12.2016/04 Title: Taking the cancer strategy forward: programme update Lead Director: Professor Sir Bruce Keogh, National Medical Director Cally Palmer, National Cancer
More informationCommissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.
Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Document Title An Overview of Commissioning Living with and Beyond Cancer in Yorkshire and Humber Version number: 1 First
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationMeeting of the SWAG Network Haematology SSG
Meeting of the SWAG Network Haematology SSG Tuesday 21 st November 2017, 14:00-16:30 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, Bristol, BS20 0HH This meeting was sponsored by Celgene and Novartis
More informationOutcomes from Local Cancer Campaigns Survey February 2016
Outcomes from Local Cancer Campaigns Survey February 2016 Purpose The purpose of this report is for the Clinical Network and our key stakeholders to understand if Local Authorities have identified specific
More informationEstablished by NHS England in 2013, we are one of 15 AHSNs across England established to spread innovation at pace and scale.
Friday 22 June 2018 @WEAHSN 1 Overview About the West of England Academic Health Science Network The West of England AHSN is delivering positive healthcare outcomes locally and nationally by driving the
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationNHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY
Agenda Item No: Part 1 X Part 2 NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 25.4.17 Title of Report Purpose of the Report Public Health Update This report provides an update to the Clinical
More informationProgress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England
Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY
More information2. The role of CCG lay members and non-executive directors
CCG Lay Members, Non-Executive Directors and STP Governance and Engagement 1. Introduction Report from network events organised by NHS England and NHS Clinical Commissioners in February 2017 This briefing
More informationDorset Health and Wellbeing Board
Dorset Health and Wellbeing Board Date of Meeting 09 November 2016 Subject of Report Sustainability and Transformation Plan Refresh Update Report Author Partner Organisation Tim Goodson, Chief Officer,
More informationThe Chair, Graham, welcomed everyone to the meeting and invited group members to introduce themselves.
West Yorkshire and Harrogate, Health and Care Partnership Lay Member Assurance Group meeting White Rose House, Wakefield Tuesday 26 September 2017 10am - 12noon Present Graham Prestwich, NHS Leeds North
More informationSouth West Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Colorectal SSG 09:30-15:30, Wednesday, 30 th November 2016 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, BS20 OHH THIS MEETING WAS SPONSORED BY NORGINE, MERCK SERONO AND
More informationNational Cancer Programme: Living With and Beyond Cancer
National Cancer Programme: Living With and Beyond Cancer Sarah Benger Senior Programme Manager, NHS England February 2017 Introduction: The Independent Cancer Taskforce Aim: To improve cancer services
More informationThe role of cancer networks in the new NHS
The role of cancer networks in the new NHS October 2012 UK Office, 89 Albert Embankment, London SE1 7UQ Questions about cancer? Call the Macmillan Support Line free on 0808 808 00 00 or visit macmillan.org.uk
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationDCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018
DCP Newsletter Issue 1 June 2018 Welcome Hello and a warm welcome to all of our readers of this first edition of the Dorset Cancer Partnership (DCP) newsletter. Each edition of this newsletter will provide
More informationCancer Transformation Programme
Cancer Transformation Programme Introduction to and supporting documentation for VALUE BASED TRANSFORMATION FUNDING SITE SELECTION November 2016 1 Introduction and Contents The Planning Guidance for 2017-2019
More informationLincolnshire JSNA: Cancer
What do we know? Summary Around one in three of us will develop cancer at some time in our lives according to our lifetime risk estimation (Sasieni PD, et al 2011). The 'lifetime risk of cancer' is an
More informationWHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE
WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed
More informationJOB DESCRIPTION. ImROC Business Manager (Mental Health Network) and Senior. Policy Manager (NHS Clinical Commissioners)
JOB DESCRIPTION Job Title: Location: Salary: Reports To: Accountable To: Team Administrator London 21,630 (plus London weighting) ImROC Business Manager (Mental Health Network) ImROC Business Manager (Mental
More informationThis paper outlines the engagement activity that took place, and provides key themes from the 57 written responses received.
Agenda item: 5.4 Subject: Presented by: Prepared by: Submitted to: Specialist Fertility Services Dr Dustyn Saint SNCCG Commissioning Team SNCCG Communications and Engagement Team SNCCG Governing Body Date:
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationFrom the Permanent Secretary and HSC Chief Executive
From the Permanent Secretary and HSC Chief Executive Dr Andrew Murrison MP Chair, N. Ireland Affairs Committee Committee Office House of Commons LONDON SW1A 0AA northircom@parliament.uk Castle Buildings
More informationSouth West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Haematology Site Specific Group (SSG) Wednesday 2 nd November 2016, 14.00-16.30 Engineers House Conference Centre, Clifton Down, Bristol Chair: Dr Deepak Mannari (DM) This meeting
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Haematology Cancer Network Site Specific Group.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Haematology Cancer Network Site Specific Group Annual Report 2014 Version 1.0 1 This annual report was prepared by: Sophie Otton Chair
More informationSheffield s Emotional Wellbeing and Mental Health Strategy for Children and Young People
Sheffield s Emotional Wellbeing and Mental Health Strategy for Children and Young People The Sheffield Vision In Sheffield we want every child and young person to have access to early help in supporting
More informationADPH Sector-Led-Improvement (SLI) Annual report template
ADPH Sector-Led-Improvement (SLI) Annual report template Annual report NB: All completed reports will be circulated among the network SLI leads as sharing good practice. Network Cheshire and Merseyside
More informationCore Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning
Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationDiabetes Network
1 Diabetes Network - 2019 Network Manager: Alison Featherstone Aims/Objectives Clinical Lead(s) Network Lead 1.0 Support the delivery of the national NHS Diabetes Prevention Programme for Dr Caroline Sprake
More informationTransforming cancer care: the bigger picture and what's next
Transforming cancer care: the bigger picture and what's next Session plan Introduction and progress of the National Cancer Programme The future of NHS cancer care in the long term plan for cancer Discussion
More informationMCIP Recruitment Pack
MCIP Recruitment Pack Page 1 of 13 Welcome Thank you for the interest you have shown in the MCIP Programme. An exciting partnership has been established to redesign cancer care in Manchester. Funded by
More informationLondon Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018
ADPH London London Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018 Improving and protecting the health of Londoners 1 Table of Contents Welcome 3 About
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationIntegrated Diabetes Care in Oxfordshire -patient's perspective. Avril Surridge
Integrated Diabetes Care in Oxfordshire -patient's perspective Avril Surridge Today How does diabetes care in Oxfordshire look like from a patient s perspective? Good things What could be improved? National
More informationNHS England (West Yorkshire) Dental Commissioning Update 2015/16
Report of NHS England North (Yorkshire and Humber) to the meeting of the Health and Social Care Overview & Scrutiny Committee to be held on 08 October 2015 Subject: NHS England (West Yorkshire) Dental
More informationHERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN
HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN 2016-2021 1 1. Introduction Herts Valleys Palliative and End of Life Care Strategy is guided by the End of Life Care Strategic
More informationNational Cancer Update. Stephen Parsons Director
National Cancer Update Stephen Parsons Director Cancer Update: An Overview The new NHS landscape Progress on cancer The new landscape The Health and Social Care Act New Ministerial Team Jeremy Hunt Earl
More informationDorset Health and Wellbeing Board
Dorset Health and Wellbeing Board Minutes of the meeting held at County Hall, Colliton Park, Dorchester, Dorset, DT1 1XJ on Wednesday, 13 September 2017 Present: Rebecca Knox (Chairman) Forbes Watson (Vice-Chairman)
More informationWest Cheshire Patient Support Group Forum
West Cheshire Patient Support Group Forum Tuesday, November 28 th 2017 Conference Rooms A & B, 1829 Building, Countess of Chester Health Park, Liverpool Road, Chester, CH2 1HJ Apologies received from:
More informationPOLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan
POLICY BRIEFING Prime Minister s challenge on dementia 2020 implementation plan Date: 14th March 2016 Author: Christine Heron LGiU associate Summary The Prime Minister s challenge on dementia contains
More informationLiving With and Beyond Cancer where next?
Living With and Beyond Cancer where next? Lesley Smith, Senior Programme Manager, LWBC, NHS England National Network of Colorectal Cancer Nurses, Sept 2018 Disclosure Trustee (unpaid) of the Pelvic Radiation
More informationReport of South Reading CCG Governing Body 7 June 2017
Agenda Item 17: SR17.06.14 Report of South Reading CCG Governing Body 7 June 2017 Title Sponsoring Director Author(s) Purpose Previously considered by Risk and Assurance Financial and resource implications
More informationSubject: NHS Screening and Immunisation Programmes T
Report of the West Yorkshire Screening and Immunisation Team to the meeting of the Health and Social Care Overview & Scrutiny Committee to be held on 7 December 2017 Subject: NHS Screening and Immunisation
More informationNHS Bowel Cancer Screening Programme
NHS Bowel Cancer Screening Programme Wolverhampton Bowel Cancer Screening Centre Annual Report April 2015 to March 2016 Introduction Bowel cancer is the fourth most common cancer in the UK (2012) accounting
More informationNational Cancer Programme: Living With and Beyond Cancer. Becky Clack Programme Manager, NHS England. September
National Cancer Programme: Living With and Beyond Cancer Becky Clack Programme Manager, NHS England September 2017 Contents 1 The Context 2 LWBC Early Priorities 3 Recovery Package & Stratified Follow-up
More informationAppendix A: SECTION THREE: Engagement & participation Activity 2014/15. Objective Area of work What we did, who we engaged and how we did it?
Procurement of a physical activity programme CANCER Macmillan Physical Activity Programme Patient involvement in procurement of Macmillan Physical Activity Programme. This was initially an Invitation to
More informationSouth Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member
Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:
More informationChildren and young people s emotional health and wellbeing transformation plan refresh 2016
Children and young people s emotional health and wellbeing transformation plan refresh 2016 October 2016 Contents 1. Introduction... 2 2. What have we achieved since our first transformation plan in 2015?...
More informationBreast Cancer Pathway Board Minutes of meeting
Breast Cancer Pathway Board Minutes of meeting Monday 9 th March 2015, 2pm 5 pm Boardroom 1, New Alderley House, Victoria Road, East Cheshire NHS Foundation Trust Attendance Mohammed Absar Chandeena Roshanlall
More informationHCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report
HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals
More informationDUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND
DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS 2013-14 AND 2014-15 RECOMMENDATION/WORKPLAN CURRENT POSITION IN D & G PLAN 1. Annual Report 1.1 Develop robust reporting mechanisms
More informationWessex Cancer Alliance. Wessex Cancer Strategic Clinical Network
Wessex Cancer Alliance Wessex Cancer Strategic Clinical Network Chair : Tim Billington Friday 11 th September 2015 Patients are our priority Patients are people Perception versus what is said Pathways
More informationThe next steps
Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater
More informationROLE SPECIFICATION FOR MACMILLAN GPs
ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting
More informationLeeds: Early Diagnosis Project updates
Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy
More informationThe NHS Cancer Plan: A Progress Report
DEPARTMENT OF HEALTH The NHS Cancer Plan: A Progress Report LONDON: The Stationery Office 9.25 Ordered by the House of Commons to be printed on 7 March 2005 REPORT BY THE COMPTROLLER AND AUDITOR GENERAL
More informationNHS Diabetes Programme
NHS Diabetes Programme London Regional Event Vision Through the NHS Diabetes Programme we will aim to slow the future growth in the incidence of diabetes and reduce the rate of complications associated
More informationStreamlining the lung diagnostic pathway (A87)
Streamlining the lung diagnostic pathway (A87) Crawley CCG with Surrey and Sussex Healthcare NHS Trust Evaluation January 2017 Summary A new Straight-to-CT pathway for patients with an abnormal CXR result
More informationVolunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland
NG11-07 ing in NHSScotland Developing and Sustaining ing in NHSScotland Outcomes The National Group for ing in NHS Scotland agreed the outcomes below which formed the basis of the programme to develop
More informationBrighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer
Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate
More informationAlliance Diagnostic Hub for NEL. Cancer Collaborative Annual Review event
Alliance Diagnostic Hub for NEL Cancer Collaborative Annual Review event 26 th June 2018 There are clear national priorities for provision of Cancer Services National Context The Five Year Forward View,
More informationNHS PREPAREDNESS FOR A MAJOR INCIDENT
NHS PREPAREDNESS FOR A MAJOR INCIDENT In light of the recent tragic events in Paris, NHS England has asked that the Trust reviews the following, and that assurance is provided in the form of a Statement
More informationItem Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING. Meeting Date: 7 November Report Author: Report Sponsor:
Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 7 November 2013 Report Sponsor: Dr Emma Broughton Clinical Lead for Primary Care Programme Report Author:
More informationLiving with and Beyond Pathway Board Minutes of Meeting
Living with and Beyond Pathway Board Minutes of Meeting 20 th January 2015 Location: Lecture Theatre 1, Department 17, The Christie NHS Foundation Trust Time: 3 to 5pm Attendance Wendy Makin Kathy Pantelides
More informationBedfordshire, Luton and Milton Keynes (BLMK) Sustainability and Transformation Partnership (STP) Central Brief: October 2017
Bedfordshire, Luton and Milton Keynes (BLMK) Sustainability and Transformation Partnership (STP) Central Brief: October 2017 Issue date: 2 November 2017 News Work progresses on proposed merger of Bedfordshire
More informationThe National perspective Public Health England s vision, mission and priorities
The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England
More informationDevon Local Pharmaceutical Committee. Meeting held on 6 th January Westbank Centre, Exminster
Devon Local Pharmaceutical Committee Meeting held on 6 th January 2015 Westbank Centre, Exminster Present: David Bearman, Chris Babbs, Sadik Al- Hassan, Nerys Cadvan-Jones, David Chapman, David Fulton,
More informationBuilding on Success. Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance. May 2015
Building on Success Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance May 2015 Introduction Cancer care in Greater Manchester has seen significant improvements in recent
More informationPROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME
PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME 1. BACKGROUND: 1.1 Primary Care 90% of mental health care is provided within primary care services, with the most common mental health problems identified
More informationImproving diagnostic pathways for patients with suspected lung cancer
Improving diagnostic pathways for patients with suspected lung cancer Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England,
More informationPRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016
Part 1 Part 2 PRIMARY CARE CO-COMMISSIONING COMMITTEE 18 March 2016 Title of Report Supporting deaf patients to access primary care services Purpose of the Report The report is to provide the co-commissioning
More informationGreater Manchester Health and Care Board
Greater Manchester Health and Care Board 7 Date: 11 May 2018 Subject: Report of: A Greater Manchester Framework to improve Palliative and End of Life Care Dr Richard Preece, Executive Lead for Quality,
More informationSimply, participation means individual s involvement in decisions that affect them.
Simply, participation means individual s involvement in decisions that affect them. NHS England guidance on participation sets out two types of participation in healthcare: 1) people s involvement in decisions
More informationDiabetes in Pregnancy Network: Scoping survey March 2013
Diabetes in Pregnancy Network: Scoping survey March 2013 Diabetes in Pregnancy Network Scoping Survey Aim To inform the development of a National Diabetes in Pregnancy Network Objectives To identify the
More informationMacmillan Cancer Improvement Partnership (MCIP) An introduction
Macmillan Cancer Improvement Partnership (MCIP) An introduction What is MCIP? The Macmillan Cancer Improvement Partnership in Manchester brings together the city s cancer care services and their funders
More informationLocal Healthwatch Quality Statements. February 2016
Local Healthwatch Quality Statements February 2016 Local Healthwatch Quality Statements Contents 1 About the Quality Statements... 3 1.1 Strategic context and relationships... 5 1.2 Community voice and
More informationIn this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care
Newsletter Summer 2016 In this edition: How Primary Care can help earlier diagnosis Improving communication between Primary & Secondary Care A new approach to longer term care How primary care is adapting
More informationCABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationGreater Manchester Cancer
In attendance Greater Manchester Cancer Board Minutes of the meeting held on Greater Manchester Cancer Friday 21 st October 2016 at Salford Royal Voting members Lead CCG Nigel Guest NG Chief Clinical Officer,
More informationSarah Ambe Team Manager, Healthwatch Bristol SA Alison Bolam GP Clinical Commissioning Area Lead (Bristol), BNSSG AB
Patient and Public Involvement Forum Minutes of the meeting held on Tuesday 17 th July 2018 at 2pm in the WG Grace Meeting Room, Lower Ground Floor, South Plaza, Marlborough Street, Bristol, BS1 3NX Minutes
More informationMinutes of Healthwatch Sefton Steering Group meeting.
Page1 Minutes of Healthwatch Sefton Steering Group meeting. Held on 11 th December 2013. Board Room. 3 rd Floor, Suite 3B, North Wing, Burlington House Crosby Road North, Waterloo. L22 0LG 1. Welcome,
More informationActivity Report April 2012 March 2013
Gynaecological Cancer Managed Clinical Network Activity Report April 2012 March 2013 Nadeem Siddiqui MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 4 2.
More informationEvaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK
Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...
More informationSOUTH EASTERN LOCAL COMMISSIONING GROUP. Personal and Public Involvement Workshop. Feedback Report Newtownards Town Hall, 3 October 2013
SOUTH EASTERN LOCAL COMMISSIONING GROUP Personal and Public Involvement Workshop Feedback Report Newtownards Town Hall, 3 October 2013 From Left to Right: Martin Quinn (Public Health Agency); Sarah McCandless
More informationNorth Somerset Autism Strategy
North Somerset Autism Strategy Approved by: Ratification date: Review date: September 2017 1 Contents 1 Introduction and background... 3 2 Defining Autism...Error! Bookmark not defined. 3 National and
More informationKirklees Safeguarding Children Board. Annual Report. January 2011 March Executive Summary.
Kirklees Safeguarding Children Board Annual Report January 2011 March 2012 Executive Summary www.kirkleessafeguardingchildren.com Foreword As the Chair of Kirklees Safeguarding Children s Board, I am pleased
More informationGetting it right: Approaches to promoting earlier diagnosis of cancer The national perspective
Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective Housekeeping Toilets Fire alarm Tea and Coffee Wifi: MSE-meeting rooms Password: mselondon Twitter - #gettingitright
More informationELR CCG Annual General Meeting. Tuesday 26 September 2017
ELR CCG Annual General Meeting Tuesday 26 September 2017 1 Programme Welcome and introductions Responses to questions submitted today A patient and carer experience - Living with Dementia An introduction
More information13 Minutes of the Board Meeting held on 7th June, 2016 (HWB /2)
MEETING: Health and Wellbeing Board DATE: Tuesday, 9 August 2016 TIME: 4.00 pm VENUE: Reception Room, Barnsley Town Hall MINUTES Present Councillor Sir Steve Houghton CBE, Leader of the Council (Chair)
More informationGP Cluster Network Action Plan Upper Valleys Cluster
GP Cluster Network Action Plan 2015-16 Upper Valleys Cluster The Cluster Network 1 Development Domain supports GP Practices to work to collaborate to: Understand local health needs and priorities. Develop
More information